Patients with allergic symptoms, nausea, vomiting, or motion sickness may be prescribed Promethazine tablets. Promethazine is a first-generation antihistamine and phenothiazine derivative that blocks…
Patients with allergic symptoms, nausea, vomiting, or motion sickness may be prescribed Promethazine tablets. Promethazine is a first-generation antihistamine and phenothiazine derivative that blocks histamine and reduces nausea, but it can also cause marked drowsiness.
Promethazine contains promethazine as its active medicinal substance and belongs to the first-generation antihistamine group. It is also classified as a phenothiazine derivative and has antiemetic properties, meaning it can help control nausea and vomiting. The tablet form is used for oral treatment when a clinician considers an antihistamine or antiemetic effect appropriate.
Promethazine may be prescribed for:
The product sold on this page is Promethazine in tablet form. Other promethazine medicines may exist as oral liquids or injectable preparations, but those forms have different strengths, dosing instructions, and clinical uses. They should not be treated as interchangeable with tablets.
Promethazine Hydrochloride is the hydrochloride salt commonly used in oral promethazine products. The active substance determines the antihistamine and antiemetic action; the tablet formulation determines how it is administered.
Brand names and formulations can differ between countries and manufacturers. For a prospective buyer, the relevant pharmaceutical facts are the active substance, tablet form, prescribed strength, and intended indication. The exact dose is decided individually, taking age, other medicines, and health conditions into account.
Promethazine may be used when histamine symptoms, nausea, or vestibular disturbance require treatment. The most common therapeutic roles are listed below.
Promethazine treats symptoms rather than the underlying cause of every condition. For example, it can reduce the discomfort of an allergic reaction, but it does not remove the trigger responsible for that reaction.
A severe allergic reaction involving breathing difficulty, throat swelling, collapse, or rapidly worsening symptoms requires emergency treatment rather than reliance on an oral antihistamine.
The prescribed dose is selected individually according to age, the reason for treatment, other medicines, and relevant health conditions. Promethazine tablets are taken by mouth at the frequency selected by the prescriber.
Practical administration points include:
Promethazine is often given in the evening when drowsiness is likely to interfere with daytime activities. That timing is not suitable for every indication, so the prescribed schedule takes priority.
The medicine is intended for the treatment period selected by the prescriber. Prolonged self-treatment can expose a person to avoidable anticholinergic effects and may mask symptoms that need further assessment.
Important situations requiring avoidance or specific medical assessment include:
Pregnancy and breastfeeding require individual assessment. Promethazine may cross the placenta and may pass into breast milk. A prescriber weighs symptom severity, gestational stage, feeding plans, and alternative treatments before recommending it.
Promethazine is not suitable for everyone. This medication is not for you if you have had a serious allergic reaction to promethazine, another phenothiazine, or an ingredient in the tablet.
The under-two age restriction is a specific safety warning. Respiratory depression can occur unpredictably and may be life-threatening. The HPRA and European medicines safety information place strong emphasis on age-related respiratory risk with sedating antihistamines [2].
Older adults can be more sensitive to confusion, falls, constipation, urinary retention, and blurred vision. A lower or less frequent dose may be selected, but the decision depends on the person’s health and concurrent medicines.
Drowsiness is one of the most recognisable effects of Promethazine. It can appear within the same treatment period as symptom relief and may last into the following morning.
Common or clinically relevant adverse effects include:
Children can sometimes develop paradoxical excitation rather than sedation. Irritability, agitation, unusual energy, or difficulty settling after a dose should be taken seriously.
Rare but serious reactions can include severe breathing difficulty, fainting, marked confusion, abnormal muscle movements, seizures, a severe skin reaction, or a serious allergic response. Emergency assessment is needed for swelling of the lips or tongue, wheezing, collapse, severe rash with blistering, or breathing that becomes slow or difficult.
A practical problem is next-day impairment. A person may sleep through the night yet still have slower reaction time the following morning. This matters for early driving, safety-critical work, and caring for young children.
Histamine is a chemical messenger released during allergic reactions. When it activates H1 receptors, it can contribute to itching, nasal discharge, sneezing, tearing, and swelling. Promethazine occupies H1 receptors and reduces this signalling.
Its effect is not limited to allergy pathways. Promethazine also influences brain areas involved in vomiting and balance, which explains its use for motion sickness and nausea. The same central activity explains why patients can experience drowsiness, slower reactions, dizziness, or impaired concentration.
Promethazine has anticholinergic activity as well. This can reduce secretions but may also produce dry mouth, blurred vision, constipation, difficulty passing urine, or confusion, especially in older adults.
The FDA prescribing information describes these sedative, antihistaminic, and antiemetic effects together [1].
Several practical errors can make Promethazine harder to use safely:
One easily missed detail is blurred vision. It can make night driving and stair use unsafe even when drowsiness feels mild.
Another is constipation. Promethazine can worsen bowel slowing when combined with other anticholinergic medicines, so new abdominal swelling, severe pain, or inability to pass stool requires prompt medical attention.
Promethazine, diphenhydramine, and meclizine are all sedating antihistamines, but their clinical roles and tolerability can differ. A prescriber chooses between them according to the symptom pattern, age, other medicines, and the need to remain alert.
| Medicine or category | Main clinical profile |
|---|---|
| Promethazine | Strong sedating antihistamine with antiemetic and anticholinergic activity; used for allergy symptoms, nausea, vomiting, and motion sickness |
| Diphenhydramine HCl | Sedating antihistamine used for allergic symptoms and selected short-term indications; may impair alertness and cause dry mouth |
| Meclizine HCl | Antihistamine commonly used for motion sickness and vestibular nausea; sedation can still occur, though the experience differs between individuals |
Promethazine may be selected when nausea and allergy symptoms overlap or when a stronger sedating effect is clinically acceptable. Meclizine may be preferred for some travel-related symptoms when a longer-lasting vestibular effect is desired. Diphenhydramine may be considered for selected allergic symptoms, but it can also cause substantial drowsiness.
None of these medicines is ideal for every patient. A person who must drive, work at height, supervise children, or make rapid decisions may need a less sedating strategy.
Clinicians generally view Promethazine as a useful but sedating medicine. Its benefits must be balanced against slower reaction time, anticholinergic effects, and the respiratory risks associated with young children.
A doctor will usually ask why the medicine is needed, whether symptoms are acute or persistent, and which medicines are already being taken. The same tablet can be reasonable for short-term motion sickness in one person but unsuitable for an older adult taking several sedatives.
Clinical assessment also considers hydration and the cause of vomiting. Persistent vomiting, blood in vomit, severe abdominal pain, high fever, or signs of dehydration should not be managed by repeatedly suppressing symptoms at home.
The EMA’s pharmacovigilance framework treats sedation, respiratory depression, and age-related vulnerability as clinically relevant factors when medicines affect the central nervous system [3].
Promethazine during pregnancy or breastfeeding requires an individual benefit–risk assessment. HPRA information published in 2024 recognises that sedating antihistamines may affect the mother, fetus, newborn, or breastfed infant depending on timing and dose. A prescriber considers the stage of pregnancy, the severity of symptoms, and whether the infant is premature or medically vulnerable. Breastfeeding may require observation for unusual sleepiness, poor feeding, or breathing changes in the infant. The FDA label from 2023 describes sedation and other adverse effects that may matter after delivery.
Promethazine tablets can generally be taken with or without food. Guidance published by the EMA in 2019 supports practical administration according to tolerability, with water used to swallow the tablet. Food may help people who notice stomach discomfort, but it does not remove the risk of drowsiness. Alcohol remains unsuitable because it can intensify central nervous system depression.
Urgent medical assessment is needed for difficult or slow breathing, collapse, severe confusion, facial or throat swelling, wheezing, seizures, or a rapidly spreading blistering rash. WHO safety principles described in 2019 treat these symptoms as possible serious reactions rather than routine side effects. Severe palpitations, uncontrolled movements, inability to pass urine, or extreme agitation also require prompt review. Do not take another dose while waiting for urgent advice unless an emergency clinician specifically instructs you to do so.
A previous serious reaction to promethazine or another phenothiazine rules out further use unless a specialist establishes a different explanation. HPRA safety information published in 2024 also supports avoiding promethazine in children under two years because of respiratory depression risk. Coma, severe breathing impairment, and some forms of urinary retention are additional situations requiring avoidance or specialist assessment. Glaucoma, prostate symptoms, and severe constipation should be disclosed before treatment.
Use in people under 18 depends on age, indication, formulation, and clinical assessment. EMA safety guidance published in 2019 places a clear restriction on promethazine use in children under two years because breathing suppression can be unpredictable. Older children and adolescents may still be vulnerable to paradoxical excitation, confusion, and excessive sedation. A parent or carer should seek medical advice promptly if the child becomes unusually restless, difficult to wake, or breathes abnormally.
Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (24x11x0.7 cm) and its contents cannot be seen.
Based on 5 reviews
I used Promethazine for travel-related nausea and found it settled my stomach before the journey. The sleepiness lasted into the next morning, so I avoided driving after taking it.
14 Oct 2026The tablet helped with sneezing and watery eyes during a bad allergy spell. Dry mouth was annoying, and I needed to keep water beside the bed.
26 Oct 2026I took it for nausea and felt dizzy when standing up during the first few hours. The symptom improved, but I would not take it before work that involves concentration.
28 Oct 2026It reduced motion sickness on a long trip, although the sedation was stronger than I expected. I avoided alcohol and did not combine it with another antihistamine.
6 Nov 2026Promethazine helped me sleep while allergy symptoms were severe, but that was also the drawback. I felt groggy the next day and asked for a different approach for daytime use.
9 Nov 2026
